Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair M Thompson

Showing results (101-110 of 195) with videos related to

Pageof 20
Sort By:
Health Technology Assessment (Winchester, England)|February 28, 2022
Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCTJulie Bruce, Bruno Mazuquin, Pankaj Mistry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phaseEmiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
Advances in Radiation Oncology|October 21, 2020
Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialBhavana V Chapman, Xiudong Lei, Prithvi Patil, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Cancer|June 16, 2016
Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiationCameron W Swanick, Xiudong Lei, Simona F Shaitelman, et al.
Ebiomedicine|May 29, 2025
Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical featuresShannon Doyle, Esther H Lips, Eric Marcus, et al.
The British Journal of Surgery|August 30, 2024
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort studySabrina M Wang, Yan Li, Amanda Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast CancerPatricia A Parker, Susan K Peterson, Yu Shen, et al.
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
Pageof 20

Showing results (101-110 of 195) with videos related to

Sort By:
Pageof 20
Health Technology Assessment (Winchester, England)|February 28, 2022
Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCTJulie Bruce, Bruno Mazuquin, Pankaj Mistry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phaseEmiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
Advances in Radiation Oncology|October 21, 2020
Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialBhavana V Chapman, Xiudong Lei, Prithvi Patil, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Cancer|June 16, 2016
Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiationCameron W Swanick, Xiudong Lei, Simona F Shaitelman, et al.
Ebiomedicine|May 29, 2025
Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical featuresShannon Doyle, Esther H Lips, Eric Marcus, et al.
The British Journal of Surgery|August 30, 2024
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort studySabrina M Wang, Yan Li, Amanda Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast CancerPatricia A Parker, Susan K Peterson, Yu Shen, et al.
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
Pageof 20